<DOC>
	<DOCNO>NCT02314806</DOCNO>
	<brief_summary>The patient undergoing axillary lymph node dissection randomize 3 group : patient undergo lavage normal saline ( Group 1 ) , patient undergoing lavage gentamicin solution ( Group 2 ) patient undergoing lavage clindamycin solution ( Group 3 ) . Drainage volume discharge investigate</brief_summary>
	<brief_title>Gentamicin Versus Clindamycin Versus Normal Saline Lavage Axilla</brief_title>
	<detailed_description>The patient undergoing axillary lymph node dissection randomize 3 group : patient undergo 2 lavage 500 ml normal saline ( Group 1 ) , patient first undergoing lavage 500 ml normal saline follow second lavage 500 ml gentamicin ( 240 mg ) solution ( Group 2 ) patient first undergoing lavage 500 ml normal saline follow second lavage 500ml clindamycin ( 600mg ) solution ( Group 3 ) . Drainage volume discharge investigate</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Gentamicins</mesh_term>
	<criteria>diagnosis breast neoplasms plan undergo elective ALND Berg 's level I II due axillary metastasis determine preoperatively core biopsy evidence metastasis SLNB intraoperative differ analysis . allergy antibiotic drug use chronic renal failure due possible toxicity gentamicin patient undergo modified radical mastectomy .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>